Header

UZH-Logo

Maintenance Infos

Browse by Creators

Navigate back| Up a level
Export as
Number of items: 30.

Attems, J; Ittner, A; Jellinger, K; Nitsch, R M; Maj, M; Wagner, L; Götz, J; Heikenwalder, M (2011). Reduced secretagogin expression in the hippocampus of P301L tau transgenic mice. Journal of Neural Transmission, 118(5):737-745.

Rhein, V; Song, X; Wiesner, A; Ittner, L M; Baysang, G; Meier, F; Ozmen, L; Bluethmann, H; Dröse, S; Brandt, U; Savaskan, E; Czech, C; Götz, J; Eckert, A (2009). Amyloid-beta and tau synergistically impair the oxidative phosphorylation system in triple transgenic Alzheimer's disease mice. Proceedings of the National Academy of Sciences of the United States of America (PNAS), 106(47):20057-20062.

Baur, K; Rauer, M; Richter, K; Pagenstecher, A; Götz, J; Hausmann, J; Staeheli, P (2008). Antiviral CD8 T cells recognize borna disease virus antigen transgenically expressed in either neurons or astrocytes. Journal of Virology, 82(6):3099-3108.

Ittner, L M; Schwerdtfeger, K; Kunz, T H; Muff, R; Husmann, K; Grimm, C; Hafezi, F; Lang, K S; Kurrer, M O; Götz, J; Born, W; Fischer, J A (2008). Transgenic mice with ocular overexpression of an adrenomedullin receptor reflect human acute angle-closure glaucoma. Clinical Science, 114(1):49-58.

Hoerndli, F J; Pelech, S; Papassotiropoulos, A; Götz, J (2007). Abeta treatment and P301L tau expression in an Alzheimer's disease tissue culture model act synergistically to promote aberrant cell cycle re-entry. European Journal of Neuroscience, 26(1):60-72.

David, D C; Ittner, L M; Gehrig, P; Nergenau, D; Shepherd, C; Halliday, G; Götz, J (2006). Beta-amyloid treatment of two complementary P301L tau-expressing Alzheimer's disease models reveals similar deregulated cellular processes. Proteomics, 6(24):6566-6577.

Kulic, L; Kurosinski, P; Chen, F; Tracy, J; Mohajeri, M H; Li, H; Nitsch, R M; Götz, J (2006). Active immunization trial in Abeta42-injected P301L tau transgenic mice. Neurobiology of Disease, 22(1):50-56.

Schild, A; Schmidt, K; Lim, Y-A; Ke, Y; Ittner, L M; Hemmings, B A; Götz, J (2006). Altered levels of PP2A regulatory B/PR55 isoforms indicate role in neuronal differentiation. International Journal of Developmental Neuroscience, 24(7):437-443.

Schild, A; Ittner, L M; Götz, J (2006). Altered phosphorylation of cytoskeletal proteins in mutant protein phosphatase 2A transgenic mice. Biochemical and Biophysical Research Communications (BBRC), 343(4):1171-1178.

Schild, A; Isenmann, S; Tanimoto, N; Tonagel, F; Seeliger, M W; Ittner, L M; Kretz, A; Ogris, E; Götz, J (2006). Impaired development of the Harderian gland in mutant protein phosphatase 2A transgenic mice. Mechanisms of Development, 123(5):362-371.

Pennanen, L; Wolfer, D P; Nitsch, R M; Götz, J (2006). Impaired spatial reference memory and increased exploratory behavior in P301L tau transgenic mice. Genes, Brain and Behavior, 5(5):369-379.

Pennanen, L; Götz, J (2005). Different tau epitopes define Abeta42-mediated tau insolubility. Biochemical and Biophysical Research Communications (BBRC), 337(4):1097-1101.

David, D C; Hoerndli, F; Götz, J (2005). Functional Genomics meets neurodegenerative disorders. Part I: transcriptomic and proteomic technology. Progress in Neurobiology, 76(3):153-168.

Hoerndli, F; David, D C; Götz, J (2005). Functional Genomics meets neurodegenerative disorders. Part II: application and data integration. Progress in Neurobiology, 76(3):169-188.

David, D C; Hauptmann, S; Scherping, I; Schuessel, K; Keil, U; Rizzu, P; Ravid, R; Dröse, S; Brandt, U; Müller, W E; Eckert, A; Götz, J (2005). Proteomic and functional analyses reveal a mitochondrial dysfunction in P301L tau transgenic mice. Journal of Biological Chemistry, 280(25):23802-23814.

Pennanen, L; Welzl, H; D'Adamo, P; Nitsch, R M; Götz, J (2004). Accelerated extinction of conditioned taste aversion in P301L tau transgenic mice. Neurobiology of Disease, 15(3):500-509.

Götz, J; Schild, A; Hoerndli, F; Pennanen, L (2004). Amyloid-induced neurofibrillary tangle formation in Alzheimer's disease: insight from transgenic mouse and tissue-culture models. International Journal of Developmental Neuroscience, 22(7):453-465.

Martens, E; Stevens, I; Janssens, V; Vermeesch, J; Götz, J; Goris, J; Van Hoof, C (2004). Genomic organisation, chromosomal localisation tissue distribution and developmental regulation of the PR61/B' regulatory subunits of protein phosphatase 2A in mice. Journal of Molecular Biology, 336(4):971-986.

Chen, F; David, D; Ferrari, A; Götz, J (2004). Posttranslational modifications of tau - role in human tauopathies and modeling in transgenic animals. Current Drug Targets, 5(6):503-515.

Hoerndli, F J; Toigo, M; Schild, A; Götz, J; Day, P J (2004). Reference genes identified in SH-SY5Y cells using custom-made gene arrays with validation by quantitative polymerase chain reaction. Analytical Biochemistry, 335(1):30-41.

Chen, F; Wollmer, M A; Hoerndli, F; Münch, G; Kuhla, B; Rogaev, E I; Tsolaki, M; Papassotiropoulos, A; Götz, J (2004). Role for glyoxalase I in Alzheimer's disease. Proceedings of the National Academy of Sciences of the United States of America (PNAS), 101(20):7687-7692.

Götz, J; Streffer, J R; David, D; Schild, A; Hoerndli, F; Pennanen, L; Kurosinski, P; Chen, F (2004). Transgenic animal models of Alzheimer's disease and related disorders: histopathology, behavior and therapy. Molecular Psychiatry, 9(7):664-683.

Rauer, M; Götz, J; Schuppli, D; Staeheli, P; Hausmann, J (2004). Transgenic mice expressing the nucleoprotein of Borna disease virus in either neurons or astrocytes: decreased susceptibility to homotypic infection and disease. Journal of Virology, 78(7):3621-3632.

Flechsig, E; Hegyi, I; Leimeroth, R; Zuniga, A; Rossi, D; Cozzio, A; Schwarz, Petra; Rülicke, T; Götz, J; Aguzzi, A; Weissmann, Charles (2003). Expression of truncated PrP targeted to Purkinje cells of PrP knockout mice causes Purkinje cell death and ataxia. The EMBO Journal, 22(12):3095-3101.

Kins, S; Kurosinski, P; Nitsch, R M; Götz, J (2003). Activation of the ERK and JNK signaling pathways caused by neuron-specific inhibition of PP2A in transgenic mice. American Journal of Pathology, 163(3):833-843.

Chen, F; Ferrari, A; Schild, A; Kurosinski, P; David, D; Hoerndli, F; Pennanen, L; Kins, S; van Dorpe, J; Nitsch, R M; Götz, J (2003). Amyloid-induced neurofibrillary tangle formation. In: Iqbal, K; Winblad, B. Alzheimer’s disease and related disorders: Research advances. Ana Aslan International Foundation, 343-354.

Ferrari, A; Hoerndli, F; Baechi, T; Nitsch, R M; Götz, J (2003). Beta-Amyloid induces paired helical filament-like tau filaments in tissue culture. Journal of Biological Chemistry, 278(41):40162-40168.

Streffer, J R; Papassotiropoulos, A; Kurosinski, P; Signorell, A; Wollmer, M A; Tsolaki, M; Iakovidou, V; Hörndli, F; Bosset, J; Götz, J; Nitsch, R M; Hock, C (2003). Saitohin gene is not associated with Alzheimer's disease. Journal of Neurology, Neurosurgery, and Psychiatry, 74(3):362-363.

Götz, J; Schild, A (2003). Transgenic and knockout models of PP2A. Methods in Enzymology, 366:390-403.

Shmerling, D; Hegyi, I; Fischer, M B; Blättler, T; Brandner, S; Götz, J; Rülicke, T; Flechsig, E; Cozzio, A; von Mering, C; Hangartner, C; Aguzzi, A; Weissmann, C (1998). Expression of amino-terminally truncated PrP in the mouse leading to ataxia and specific cerebellar lesions. Cell, 93(2):203-214.

This list was generated on Tue Mar 26 09:24:37 2019 CET.